Short answer
CTS CORP (CTS) filed an 8-K current report with the SEC on July 28, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). CTS announced second-quarter results for the period ended June 30, 2026.
CTS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- CTS announced second-quarter results for the period ended June 30, 2026
- Detailed financial results and management commentary are in Exhibit 99.1, the accompanying press release
Item 7.01 · Regulation FD Disclosure
- CTS webcast scheduled for July 28, 2026, covering second-quarter results ended June 30, 2026
- Investor presentation slides furnished as Exhibit 99.2, providing supporting detail for the earnings discussion
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales $144.8M, up 7% YoY; diversified markets rose 15% and reached 59% of revenue
- Adjusted gross margin 41.5% vs 38.7%; adjusted EBITDA margin 25.4% vs 23.0%
- Adjusted diluted EPS $0.74 vs $0.57; operating cash flow increased to $33.4M from $28.4M
- 2026 sales guidance raised to $565–$585M from $560–$580M
- 2026 adjusted diluted EPS guidance raised to $2.55–$2.70 from $2.35–$2.45
Item EX-99.2 · Exhibit EX-99.2
- Q2 revenue $144.8M, up 7% YoY and 4% sequentially, signaling broad-based operating momentum
- Adjusted diluted EPS $0.74 vs $0.57, with adjusted gross margin expanding 270 bps to 41.5%
- Diversified end markets grew 15%, led by Medical up 45% and Industrial up 16%
- Transportation declined 2%, but $1.2B total booked business and $163M of quarterly wins support future revenue visibility
- FY2026 revenue guidance $565M-$585M, with $41M YTD free cash flow supporting shareholder returns and strategic M&A
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CTS CORP 8-K filings
Get the next CTS 8-K as it lands
Follow CTS for push alerts, or ask the research agent what this filing means.